Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome (Q33788054)

29 July 2017

title

Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome (English)

1 reference

29 July 2017

0 references

0 references

1 reference

bronchiolitis obliterans

1 reference

Raksha Jain

1 reference

29 July 2017

Ramsey R Hachem

1 reference

29 July 2017

Matthew R Morrell

1 reference

29 July 2017

Elbert P Trulock

1 reference

29 July 2017

Murali M Chakinala

1 reference

29 July 2017

Roger D Yusen

1 reference

29 July 2017

Howard J Huang

1 reference

29 July 2017

Thalachallour Mohanakumar

1 reference

29 July 2017

G Alexander Patterson

1 reference

29 July 2017

Michael J Walter

1 reference

29 July 2017

publication date

4 February 2010

1 reference

The Journal of Heart and Lung Transplantation

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

531-537

1 reference

Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

The significance of a single episode of minimal acute rejection after lung transplantation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Azithromycin: a plea for multicenter randomized studies in lung transplantation

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Possible interaction between intravenous azithromycin and oral cyclosporine

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854291

Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant

30 October 2018

1 reference

12 December 2020

Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation

1 reference

12 December 2020

Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation

1 reference

12 December 2020

Bronchiolitis obliterans in single-lung transplant recipients

1 reference

12 December 2020

Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group

1 reference

12 December 2020

Long-term azithromycin may improve lung function in children with cystic fibrosis

1 reference

12 December 2020

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin

1 reference

12 December 2020

Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome

1 reference

12 December 2020

Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome

1 reference

12 December 2020

10.1016/J.HEALUN.2009.12.003

Identifiers

DOI

1 reference

release_ex7d4jjh35dtlhzcdjghxjepti

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ex7d4jjh35dtlhzcdjghxjepti

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2854291

1 reference

29 July 2017

1 reference